Literature DB >> 18931339

TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.

Hong-Yan Du1, Elena Pumbo, Jennifer Ivanovich, Ping An, Richard T Maziarz, Ulrike M Reiss, Deborah Chirnomas, Akiko Shimamura, Adrianna Vlachos, Jeffrey M Lipton, Rakesh K Goyal, Frederick Goldman, David B Wilson, Philip J Mason, Monica Bessler.   

Abstract

Dyskeratosis congenita (DC) is a rare inherited form of bone marrow failure (BMF) caused by mutations in telomere maintaining genes including TERC and TERT. Here we studied the prevalence of TERC and TERT gene mutations and of telomere shortening in an unselected population of patients with BMF at our medical center and in a selected group of patients referred from outside institutions. Less than 5% of patients with BMF had pathogenic mutations in TERC or TERT. In patients with BMF, pathogenic TERC or TERT gene mutations were invariably associated with marked telomere shortening (<< 1st percentile) in peripheral blood mononuclear cells (PBMCs). In asymptomatic family members, however, telomere length was not a reliable predictor for the presence or absence of a TERC or TERT gene mutation. Telomere shortening was not pathognomonic of DC, as approximately 30% of patients with BMF due to other causes had PBMC telomere lengths at the 1st percentile or lower. We conclude that in the setting of BMF, measurement of telomere length is a sensitive but nonspecific screening method for DC. In the absence of BMF, telomere length measurements should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931339      PMCID: PMC2615648          DOI: 10.1182/blood-2008-07-166421

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  Protein composition of catalytically active human telomerase from immortal cells.

Authors:  Scott B Cohen; Mark E Graham; George O Lovrecz; Nicolai Bache; Phillip J Robinson; Roger R Reddel
Journal:  Science       Date:  2007-03-30       Impact factor: 47.728

2.  Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.

Authors:  Hiroki Yamaguchi; Rodrigo T Calado; Hinh Ly; Sachiko Kajigaya; Gabriela M Baerlocher; Stephen J Chanock; Peter M Lansdorp; Neal S Young
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

3.  Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.

Authors:  Joshua J Field; Philip J Mason; Ping An; Yumi Kasai; Michael McLellan; Sara Jaeger; Yvonne J Barnes; Allison A King; Monica Bessler; David B Wilson
Journal:  J Pediatr Hematol Oncol       Date:  2006-07       Impact factor: 1.289

4.  Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.

Authors:  Tom J Vulliamy; Amanda Walne; Aroon Baskaradas; Philip J Mason; Anna Marrone; Inderjeet Dokal
Journal:  Blood Cells Mol Dis       Date:  2005 May-Jun       Impact factor: 3.039

5.  The effect of TERC haploinsufficiency on the inheritance of telomere length.

Authors:  Fred Goldman; Rachida Bouarich; Shashikant Kulkarni; Sara Freeman; Hong-Yan Du; Lea Harrington; Philip J Mason; Arturo Londoño-Vallejo; Monica Bessler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

Review 6.  Bone marrow failure syndromes.

Authors:  B P Alter
Journal:  Clin Lab Med       Date:  1999-03       Impact factor: 1.935

7.  Dyskeratosis Congenita (DC) Registry: identification of new features of DC.

Authors:  S Knight; T Vulliamy; A Copplestone; E Gluckman; P Mason; I Dokal
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

Review 8.  Current diagnosis of inherited bone marrow failure syndromes.

Authors:  Hannah Tamary; Blanche P Alter
Journal:  Pediatr Hematol Oncol       Date:  2007-03       Impact factor: 1.969

9.  Telomerase mutations in families with idiopathic pulmonary fibrosis.

Authors:  Mary Y Armanios; Julian J-L Chen; Joy D Cogan; Jonathan K Alder; Roxann G Ingersoll; Cheryl Markin; William E Lawson; Mingyi Xie; Irma Vulto; John A Phillips; Peter M Lansdorp; Carol W Greider; James E Loyd
Journal:  N Engl J Med       Date:  2007-03-29       Impact factor: 91.245

10.  Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.

Authors:  Amanda J Walne; Tom Vulliamy; Anna Marrone; Richard Beswick; Michael Kirwan; Yuka Masunari; Fat-Hia Al-Qurashi; Mahmoud Aljurf; Inderjeet Dokal
Journal:  Hum Mol Genet       Date:  2007-05-16       Impact factor: 6.150

View more
  71 in total

Review 1.  Telomerase and idiopathic pulmonary fibrosis.

Authors:  Mary Armanios
Journal:  Mutat Res       Date:  2011-11-04       Impact factor: 2.433

2.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

Review 3.  The genetics of dyskeratosis congenita.

Authors:  Philip J Mason; Monica Bessler
Journal:  Cancer Genet       Date:  2011-12

Review 4.  Clinical management of aplastic anemia.

Authors:  Amy E Dezern; Robert A Brodsky
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

5.  Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?

Authors:  Jakob R Passweg; André Tichelli
Journal:  Haematologica       Date:  2009-03       Impact factor: 9.941

6.  Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.

Authors:  Hunter Hoffman; Cory Rice; Emmanuel Skordalakes
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

7.  Architecture of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

8.  Clinical utility gene card for: dyskeratosis congenita.

Authors:  Inderjeet Dokal; Tom Vulliamy; Philip Mason; Monica Bessler
Journal:  Eur J Hum Genet       Date:  2011-05-25       Impact factor: 4.246

9.  A homozygous telomerase T-motif variant resulting in markedly reduced repeat addition processivity in siblings with Hoyeraal Hreidarsson syndrome.

Authors:  Maria M Gramatges; Xiaodong Qi; Ghadir S Sasa; Julian J-L Chen; Alison A Bertuch
Journal:  Blood       Date:  2013-03-28       Impact factor: 22.113

10.  Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.

Authors:  Alberto Diaz de Leon; Jennifer T Cronkhite; Anna-Luise A Katzenstein; J David Godwin; Ganesh Raghu; Craig S Glazer; Randall L Rosenblatt; Carlos E Girod; Edward R Garrity; Chao Xing; Christine Kim Garcia
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.